Poly(ADP-Ribose) Polymerase-1 Is a Determining Factor in Crm1-Mediated Nuclear Export and Retention of p65 NF-κB upon TLR4 Stimulation-Reference-Cited by-同舟云学术

Poly(ADP-Ribose) Polymerase-1 Is a Determining Factor in Crm1-Mediated Nuclear Export and Retention of p65 NF-κB upon TLR4 Stimulation

Published:2010-07-07 Issue:3 Volume:185 Page:1894-1902
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Zerfaoui Mourad,Errami Youssef,Naura Amarjit S.,Suzuki Yasuhiro,Kim Hogyoung,Ju Jihang,Liu Tao,Hans Chetan P.,Kim Jong G.,Abd Elmageed Zakaria Y.,Koochekpour Shahriar,Catling Andrew,Boulares A. Hamid

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference45 articles.

1. Physiology and pathophysiology of poly(ADP-ribosyl)ation *

2. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion

3. Novel Isoquinolinone-Derived Inhibitors of Poly(ADP-ribose) Polymerase-1: Pharmacological Characterization and Neuroprotective Effects in an in Vitro Model of Cerebral Ischemia

4. Role of PARP Under Stress Conditions: Cell Death or Protection?

5. Gene Knockout or Pharmacological Inhibition of Poly(ADP-Ribose) Polymerase-1 Prevents Lung Inflammation in a Murine Model of Asthma

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Veliparib exerts protective effects in intracerebral hemorrhage mice by inhibiting the inflammatory response and accelerating hematoma resolution;Brain Research;2024-09

2. Expanding the Perspective on PARP1 and Its Inhibitors in Cancer Therapy: From DNA Damage Repair to Immunomodulation;Biomedicines;2024-07-20

3. Post-translational modifications of p65: state of the art;Frontiers in Cell and Developmental Biology;2024-07-10

4. Poly (ADP-ribose) polymerase 1 promotes HuR/ELAVL1 cytoplasmic localization and inflammatory gene expression by regulating p38 MAPK activity;Cellular and Molecular Life Sciences;2024-06-09

5. Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: Past, present, and future;Ageing Research Reviews;2023-11